BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2283721)

  • 1. Comparisons of interval breast cancers with other breast cancers detected through mass screening and in outpatient clinics in Japan.
    Yoshida K; Abe R; Itoh S; Taguchi T; Ohta J; Morimoto T; Ishida T; Tashiro H; Ogita M; Kido C
    Jpn J Clin Oncol; 1990 Dec; 20(4):374-9. PubMed ID: 2283721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A comparative analysis of interval breast cancer with breast cancer detected by mass screening or in outpatient clinics].
    Komaki K; Morimoto T; Oshimo K; Mori T; Sasa M; Konishi Y; Monden Y
    Nihon Geka Gakkai Zasshi; 1992 Apr; 93(4):413-8. PubMed ID: 1603047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The characteristics of interval breast cancer in mass screening.
    Morimoto T; Komaki K; Oshimo K; Miki H; Sasa M; Mori T; Tsuzuki H; Kamamura Y; Monden Y
    Tokushima J Exp Med; 1992 Dec; 39(3-4):109-16. PubMed ID: 1295127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mass screening for breast cancer in Japan].
    Ota J
    Gan To Kagaku Ryoho; 1991 Oct; 18(13):2210-6. PubMed ID: 1929440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Breast cancer detected by mass screening using physical examination alone].
    Morimoto T; Komaki K; Monden Y
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):944-51. PubMed ID: 3389838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved survival rate for women with interval breast cancer - results from the breast cancer screening programme in Malmö, Sweden 1976-1999.
    Zackrisson S; Janzon L; Manjer J; Andersson I
    J Med Screen; 2007; 14(3):138-43. PubMed ID: 17925086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current problems in mass screening for breast cancer].
    Morimoto T; Yamakawa T; Mitsuyama N
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2273-83. PubMed ID: 4073925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mass screening for breast cancer in Gunma prefecture--the results for 8 years and future problems].
    Ishida T; Yokoe T; Ogawa T; Kurosumi M; Kurebayashi J; Yoshida M; Yamada I; Iino Y; Izuo M
    Nihon Gan Chiryo Gakkai Shi; 1989 Oct; 24(10):2400-10. PubMed ID: 2614178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of prognostic and socio-economic factors in screen-detected and symptomatic cases of breast cancer.
    Garvican L; Littlejohns P
    Public Health; 1998 Jan; 112(1):15-20. PubMed ID: 9490883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of screen-detected breast cancers: results of a population based study.
    Cortesi L; Chiuri VE; Ruscelli S; Bellelli V; Negri R; Rashid I; Cirilli C; Fracca A; Gallo E; Federico M
    BMC Cancer; 2006 Jan; 6():17. PubMed ID: 16430776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minority report - false negative breast assessment in women recalled for suspicious screening mammography: imaging and pathological features, and associated delay in diagnosis.
    Ciatto S; Houssami N; Ambrogetti D; Bonardi R; Collini G; Del Turco MR
    Breast Cancer Res Treat; 2007 Sep; 105(1):37-43. PubMed ID: 17115112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nationwide breast cancer screening fully accomplished; results from the implementation phase 1990-1997. National Evaluation Team for Breast Cancer Screening].
    Ned Tijdschr Geneeskd; 2000 Jun; 144(23):1124-9. PubMed ID: 10876708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence-free survival in patients with small breast cancer. An analysis of cancers 10 mm or less detected clinically and by screening.
    Arnesson LG; Smeds S; Fagerberg G
    Eur J Surg; 1994 May; 160(5):271-6. PubMed ID: 8075195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interval breast cancers: prognostic features and survival by subtype and time since screening.
    Porter GJ; Evans AJ; Burrell HC; Lee AH; Ellis IO; Chakrabarti J
    J Med Screen; 2006; 13(3):115-22. PubMed ID: 17007651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of a cancer screening program on breast cancer stage at diagnosis in a medically underserved urban community.
    Oluwole SF; Ali AO; Adu A; Blane BP; Barlow B; Oropeza R; Freeman HP
    J Am Coll Surg; 2003 Feb; 196(2):180-8. PubMed ID: 12595043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Incidence and prognostic factors of breast cancer diagnosed within and outside of the organised screening program in the department of Loire-Atlantique (1991-2002)].
    Molinié F; Billon-Delacour S; Allioux C; Blais S; Bercelli P; Lombrail P
    Rev Epidemiol Sante Publique; 2008 Feb; 56(1):41-9. PubMed ID: 18295424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of the clinical features of uterine cervical cancers detected by mass screening and voluntary visit].
    Yoh S; Hasuo Y; Tanaka H; Yakushizi M; Sakurai T
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1949-57. PubMed ID: 3382243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-specific interval breast cancers in New South Wales and meta-analysis of studies of women aged 40-49 years.
    Taylor R; Page A; Bampton D; Estoesta J; Rickard M
    J Med Screen; 2004; 11(4):199-206. PubMed ID: 15563775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.